COVID-19 death toll in Olongapo now at 85 | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

COVID-19 death toll in Olongapo now at 85

/ 02:00 PM May 26, 2021

OLONGAPO CITY –– COVID-19 has claimed the life of another elderly patient here Tuesday, an official said.

In a statement, Mayor Rolen Paulino Jr. said the 79-year-old woman from Barangay Old Cabalan suffered from hypertension. She experienced difficulty in breathing on May 9 and was hospitalized that day.

Ten days later, the patient had tested positive for COVID-19 and eventually died in less than a week while in the hospital.

Article continues after this advertisement

Paulino said the patient was the 85th COVID-19-related death in the city, which has been seeing at least one death in the last five days. Most of them were elderly residents

FEATURED STORIES

The city also logged 26 new cases on Tuesday, raising to 197 the number of active infections. The fresh cases are aged 10-74.

So far, Olongapo has registered 1,855 COVID-19 cases since last year but 1,573 of them had already recovered from the disease. INQ

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

TAGS: COVID-19, elderly, Olongapo City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.